Wheen covers the Healthcare sector, focusing on stocks such as Ramsay Health Care, Telix Pharmaceuticals, and Sonic Healthcare Limited. According to TipRanks, Wheen has an average return of 9.3% and a 50.00% success rate on recommended stocks.
Currently, the analyst consensus on Healius Limited is a Moderate Sell with an average price target of €0.28, representing a -39.78% downside. In a report released on August 20, Jefferies also maintained a Hold rating on the stock with a A$0.41 price target.
Based on Healius Limited’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of A$685.1 million and a GAAP net loss of A$385.2 million. In comparison, last year the company earned a revenue of A$681.9 million and had a GAAP net loss of A$138.4 million
